ARCHIVES

Satraplatin Improved PFS In Refractory Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

NCCS Networker Volume 1 Issue 3, Fall 1987

September 13, 1987

Tarceva Added To Gemcitabine Improves Pancreatic Cancer Survival, Study Finds

February 25, 2005

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control

October 31, 1997